Volume 29, Issue 11-12

Search all Mammalian Genome articles

December 2018

Special Issue: Inflammation and Immunity in Cancer

Issue Editors:

Viive M Howell,
Andreas Behren,
Daniel Speidel,
George Kollias

16 articles in this issue

Introduction to Mammalian Genome special issue: inflammation and immunity in cancer
Andreas Behren
Daniel Speidel
Viive M. Howell
EditorialNotes 02 November 2018 Pages: 691 - 693
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer
Hauke Stamm
Jasmin Wellbrock
Walter Fiedler
ReviewPaper 21 August 2018 Pages: 694 - 702
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Perspective: cancer vaccines in the era of immune checkpoint blockade
Jonathan Cebon
ReviewPaper Open access 16 November 2018 Pages: 703 - 713
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Identifying neoantigens for use in immunotherapy
Sharon Hutchison
Antonia L. Pritchard
ReviewPaper Open access 24 August 2018 Pages: 714 - 730
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer
Emma Peel
Katherine Belov
ReviewPaper 17 September 2018 Pages: 731 - 738
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells
Kavitha Gowrishankar
Lucy Birtwistle
Kenneth Micklethwaite
ReviewPaper 09 July 2018 Pages: 739 - 756
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
The role of proteomics in the age of immunotherapies
Sarah A. Hayes
Stephen Clarke
Viive M. Howell
ReviewPaper 25 July 2018 Pages: 757 - 769
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Correction to: The role of proteomics in the age of immunotherapies
Sarah A. Hayes
Stephen Clarke
Viive M. Howell
Correction 29 October 2018 Pages: 770 - 770
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell populations?
Samantha L. Ginn
Matthew P. McCormack
Ian E. Alexander
ReviewPaper 04 September 2018 Pages: 771 - 776
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Roles of cytotoxic and helper innate lymphoid cells in cancer
Camille Guillerey
ReviewPaper 03 September 2018 Pages: 777 - 789
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
B cells and antibody production in melanoma
Jessica Da Gama Duarte
Janique M. Peyper
Jonathan M. Blackburn
ReviewPaper 03 September 2018 Pages: 790 - 805
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
The intertwined fates of inflammation and coagulation in glioma
Angela Cho
Kelly J. McKelvey
Amanda L. Hudson
ReviewPaper 30 July 2018 Pages: 806 - 816
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
NLRP3 inflammasome in colitis and colitis-associated colorectal cancer
Agampodi Promoda Perera
Karishma Sajnani
Heinrich Körner
ReviewPaper 11 September 2018 Pages: 817 - 830
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation
Marina Kazantseva
Sunali Mehta
Antony W. Braithwaite
ReviewPaper 10 July 2018 Pages: 831 - 842
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Radiation, inflammation and the immune response in cancer
Kelly J. McKelvey
Amanda L. Hudson
Connie I. Diakos
ReviewPaper Open access 03 September 2018 Pages: 843 - 865
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer
Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms
Su Yin Lim
Helen Rizos
ReviewPaper Open access 02 July 2018 Pages: 866 - 878
Part of 1 collection:

Special Issue: Inflammation and Immunity in Cancer

Volume 29, Issue 11-12

Introduction to Mammalian Genome special issue: inflammation and immunity in cancer

Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer

Perspective: cancer vaccines in the era of immune checkpoint blockade

Identifying neoantigens for use in immunotherapy

Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer

Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells

The role of proteomics in the age of immunotherapies

Correction to: The role of proteomics in the age of immunotherapies

Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell populations?

Roles of cytotoxic and helper innate lymphoid cells in cancer

B cells and antibody production in melanoma

The intertwined fates of inflammation and coagulation in glioma

NLRP3 inflammasome in colitis and colitis-associated colorectal cancer

A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation

Radiation, inflammation and the immune response in cancer

Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms

Navigation